Productsproducts -



  1. Our combination not only affords T cell-mediated cytotoxicity but also preserves all the effectors of the function of Rituximab.
  2. Provides Lower Pricing! Since Naked Antibody is Less Sophisticated than Bispecific Antibody. And by Biosimilar, Price Could be Further Marked Down.
  3. The exploitation of approved Rituximab whose efficacy, specificity, and safety have been confirmed in clinics.

To find further information, please mail to